<DOC>
	<DOCNO>NCT02762162</DOCNO>
	<brief_summary>ONASSIST registry coronary ill patient functional test measure anti-platelet effect and/or genetic profile response anti-platelet drug .</brief_summary>
	<brief_title>Registry Coronary Artery Ill Patients With Platelet Test Results</brief_title>
	<detailed_description>The Onassist Project assistance cardiologist establish individual risk stent thrombosis patient base : - functional approach ( evaluation antiplatelet effect antiplatelet regimen multiple test ) - pharmacogenomic approach ( genetic profile response antiplatelet agent ) It provide advice specific therapeutic identification adverse drug interaction , treatment compliance issue true genetic , functional mixed resistance . This individualized strategy allow adjust choice drug optimal dosage consider best benefit - risk ratio . Follow regularly make identify marker MACE ( major adverse cardiac event ) bleeding .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<criteria>coronary disease antiplatelets test performed part usual care / gentic profile antiplatelet response do patient refuse part registry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>antiplatelet</keyword>
	<keyword>stent thrombosis</keyword>
</DOC>